Blood Test For Viruses Linked to Leukemias

A new blood test has been approved by the FDA to find viruses in the blood that may lead to leukemias and neurologic diseases.  Avioq HTLV-I/II Microelisa System is the name of the testing for viruses that can be transmitted through blood transfusions, infected syringes and breast milk of an infested mother.

Avioq HTLV-I/II Microelisa System, is the only test now available that can be used to both screen the blood supply for antibodies to Human T-Lymphotropic Virus Type I (HTLV-I) and Human T-Lymphotropic Virus Type II (HTLV-II), and help diagnose infection with these viruses.

This is test will also used to test serum and plasma of potential blood donors. This gives even more confidence for blood transfusion recipients
"For many years, the donor screening community has been limited to one option for HTLV testing. We are pleased to be able to address this need by providing the Avioq HTLV-I/II assay as an alternative test," said Chamroen Chetty, CEO of Avioq, Inc. Dr. Chetty continues, "As we announced last year, Ortho Clinical Diagnostics will distribute the Avioq assay into the donor screening market, adding HTLV-I/II to their extensive menu of assays. We are pleased to have a partner who is as committed as we are to the donor screening community." The introduction of the Avioq® HTLV-I/II Microelisa System fulfills Avioq's commitment to expand its Retrovirus product portfolio.

For more information: http://www.news-medical.net/news/20120329/FDA-approves-Avioq-HTLV-III-Microelisa-System.aspx